NFKB1 and cancer: Our proposed method demonstrated high accuracy in identifying NFκB/TNF hallmark genes in 13 out of 16 cancer types (AUC ≥ 0.75, Fig. 1c) and performed even better in the pan-cancer model (AUC = 0.94, Fig. 1d).